Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group
(Q40944828)
scientific article published on January 1996
scientific article published on January 1996
Language:
other details
| description | scientific article published on January 1996 |
External Links
| (P356) |
10.1016/S0090-4295(96)80010-0
|
| (P698) |
8560679
|